| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/29/2000 | US6030831 Tie ligand homologues |
| 02/29/2000 | US6030822 Amino acid sequence; for treating skeletal muscle diseases, alzheimer's disease, or peripheral neuropathies in a mammal with an agonist or antagonist of kinase activity; antidiabetic agents |
| 02/29/2000 | US6030811 Polynucleotides encoding a human mystrophin clone, HSABH01 |
| 02/29/2000 | US6030793 Immunoassay for detecting a cell proliferation disorder using antibodies against proteins with a defined expression in prostate tissue; for diagnosis and monitoring the stage of malignancy |
| 02/29/2000 | US6030790 Kit for detecting active human parathyroid hormone including two sets of antibodies or antibody fragments; for diagnosis |
| 02/29/2000 | US6030772 Neutralizing antibodies against HIV infection |
| 02/29/2000 | US6030769 Strains of human immunodeficiency virus; for use as sensitive diagnositic agents and immunogenic compositions |
| 02/29/2000 | US6030626 Method for preparing the fimbrin protein of Haemophilus influenzae |
| 02/29/2000 | US6030625 Bordetella pertussis and Bordetella parapertussis strains |
| 02/29/2000 | US6030622 Herbal extract composition and method with immune-boosting capability |
| 02/29/2000 | US6030619 Molecular mimetics of meningococcal B epitopes |
| 02/29/2000 | US6030618 Therapeutic and prophylactic methods using heat shock proteins |
| 02/29/2000 | US6030617 Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation |
| 02/29/2000 | US6030615 Combination method for treating diseases caused by cytokine-mediated toxicity |
| 02/29/2000 | US6030613 Receptor specific transepithelial transport of therapeutics |
| 02/29/2000 | CA2182207C Paramunity inducer based on combinations of poxvirus components, process to prepare it and its use as medicament |
| 02/29/2000 | CA2093928C Monoclonal antibodies for detection and treatment of cancer |
| 02/29/2000 | CA2077753C Purified gp120 composition retaining natural conformation |
| 02/29/2000 | CA2033347C Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 02/29/2000 | CA1340914C Oligopeptides and their use for diagnostic and vaccination purposes for aids and arc |
| 02/28/2000 | CA2249037A1 Novel compounds |
| 02/24/2000 | WO2000009733A1 Intracellular delivery vehicles |
| 02/24/2000 | WO2000009711A2 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1) |
| 02/24/2000 | WO2000009702A1 Cold-adapted equine influenza viruses |
| 02/24/2000 | WO2000009701A1 Pestivirus vaccination |
| 02/24/2000 | WO2000009699A2 Method for producing yeast expressed hpv types 6 and 16 capsid proteins |
| 02/24/2000 | WO2000009694A1 Cloning of basb023 antigen from moraxella catarrhalis |
| 02/24/2000 | WO2000009691A2 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 02/24/2000 | WO2000009671A1 Process for purifying human papillomavirus virus-like particles |
| 02/24/2000 | WO2000009670A1 Purified human papillomavirus |
| 02/24/2000 | WO2000009560A2 Generation of modified molecules with increased serum half-lives |
| 02/24/2000 | WO2000009552A1 Secreted proteins and polynucleotides encoding them |
| 02/24/2000 | WO2000009541A1 nrdE |
| 02/24/2000 | WO2000009164A1 Antibodies for use in targeted and temporary treatment of humans and animals |
| 02/24/2000 | WO2000009160A1 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 02/24/2000 | WO2000009159A1 Compositions of cpg and saponin adjuvants and methods thereof |
| 02/24/2000 | WO2000009157A1 Protein delivery system using human papillomavirus virus-like particles |
| 02/24/2000 | WO2000009155A1 Methods and compositions for preventing anti-gal production in xenograft recipients |
| 02/24/2000 | WO2000009154A1 Bacterial superantigen vaccines |
| 02/24/2000 | WO2000009145A1 Treatment of tumors with oligonucleotides directed to insulin-like growth factor-i receptor |
| 02/24/2000 | WO2000009140A1 Composition and method of using tumor cells |
| 02/24/2000 | WO2000009120A1 New use of taxoid derivatives |
| 02/24/2000 | WO2000009073A2 Blood-brain barrier therapeutics |
| 02/24/2000 | WO2000001345A3 Use of an amphipathic compound for providing an adjuvant to a subunit vaccine |
| 02/24/2000 | WO1999065947A3 Monoclonal antibodies directed against the g3bp protein, and uses |
| 02/24/2000 | WO1999065461A3 Cationic amphiphile micellar complexes |
| 02/24/2000 | WO1999058685A3 Basb028 polypeptides and polynucleotides encoding therefor from moraxella catarrhalis |
| 02/24/2000 | WO1999058684A3 Compounds from moraxella catarrhalis |
| 02/24/2000 | WO1999009139A9 Retrovirus and viral vectors |
| 02/24/2000 | DE19837015A1 New human soluble guanylate cyclase alpha1/beta1 and the nucleic acid encoding the subunits, useful for producing diagnostic antibodies, and for somatic gene therapy of arteriosclerosis |
| 02/24/2000 | DE19828624C1 Modular aufgebaute RNA-Moleküle mit zwei Sequenzbereichstypen Modular RNA molecules with two types of sequence region |
| 02/24/2000 | CA2341029A1 Generation of modified molecules with increased serum half-lives |
| 02/24/2000 | CA2340418A1 Blood-brain barrier therapeutics |
| 02/24/2000 | CA2340392A1 Cloning of basb023 antigen from moraxella catarrhalis |
| 02/24/2000 | CA2340116A1 Antibodies for use in targeted and temporary treatment of humans and animals |
| 02/24/2000 | CA2340091A1 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 02/24/2000 | CA2339858A1 Treatment of tumors with oligonucleotides directed to insulin-like growth factor-i receptor |
| 02/24/2000 | CA2339748A1 Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders |
| 02/24/2000 | CA2339304A1 Composition and method of using tumor cells |
| 02/24/2000 | CA2339047A1 Secreted proteins and polynucleotides encoding them |
| 02/24/2000 | CA2338184A1 Bacterial superantigen vaccines |
| 02/24/2000 | CA2280582A1 Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus |
| 02/23/2000 | EP0980526A1 Inhibitors of nuclear protein/nuclear receptor interaction |
| 02/23/2000 | EP0980434A1 Intracellular production of hepatitis c e1 and e2 truncated polypeptides |
| 02/23/2000 | EP0980427A1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes |
| 02/23/2000 | EP0980390A2 Human-cd28 specific monoclonal antibodies for antigen non-specific activation of t-lymphocytes |
| 02/23/2000 | EP0980389A1 Antigen |
| 02/23/2000 | EP0980387A1 Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays |
| 02/23/2000 | EP0980259A1 Use of a cd40:cd154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection |
| 02/23/2000 | EP0980258A1 Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy |
| 02/23/2000 | EP0980257A1 Use of virus-like particles as adjuvants |
| 02/23/2000 | EP0980251A1 Tissue factor for influencing blood vessel formation |
| 02/23/2000 | EP0980249A1 Use of cd26 inhibitor for the manufacture of a medicament for the treatment of hiv |
| 02/23/2000 | EP0980204A1 76 kDa, 32 kDa, AND 50 kDa HELICOBACTER POLYPEPTIDES AND CORRESPONDING POLYNUCLEOTIDE MOLECULES |
| 02/23/2000 | CN1049686C Diagnostics and vaccines for hepatits virus non-A and non-B |
| 02/22/2000 | US6028184 For transgenic cells; for diagnosis of hypoglycemia, psychological and brain disorders; antidiabetic/hyperglycemic agents |
| 02/22/2000 | US6028175 Amino acid sequence; for pharmacology and screening of agonists and antagonists |
| 02/22/2000 | US6028049 Compositions comprising the Tbp2 subunit of the transferrin receptor of Neisseria meningitidis |
| 02/22/2000 | US6027935 Gene up-regulated in regenerating liver |
| 02/22/2000 | US6027934 Nucleic acid and vectors encoding an immunodominant fragment of a unique protein antigen originally derived from trypanosoma brucei rhodesiense organisms can induce immunoprotection such as against trypanosomes, leishmania |
| 02/22/2000 | US6027927 Human trk receptors and neurotrophic factor inhibitors |
| 02/22/2000 | US6027921 Chimeric proteins for use in transport of a selected substance into cells and DNA encoding chimeric proteins |
| 02/22/2000 | US6027920 System for protein expression and secretion especially in corynebacteria |
| 02/22/2000 | US6027914 Cytokine response (cr) genes |
| 02/22/2000 | US6027905 Methods for the detection of cervical cancer |
| 02/22/2000 | US6027896 Providing a prognosis in subjects previously diagnosed with alzheimer's by identifying the apolipoprotein e type isoforms; then providing prognosis based on the presence or absence of an apolipoprotein e type 4 (apoe4) isoform |
| 02/22/2000 | US6027887 Screening for preneoplastic/neoplastic disease using a nucleic acid based assay to determine whether mn oncogene expression is present in a vertebrate; and if present, determining if vertebrate is at risk of neoplastic disease |
| 02/22/2000 | US6027878 A nucleic acid sequence; diagnosis of helicobacter infections, ulcers and gastrointestinal disorders |
| 02/22/2000 | US6027736 An avian vaccine for immunizing, esp. poultry, comprising four siderophore receptor, outer-membrane proteins of enterobacter and a non-iron-regulated outer membrane protein from enterobacter/pasteurella; broad-basedcross-protection |
| 02/22/2000 | US6027735 Improving nutrient utilization in an animal or human by immunizing orally or parenterally with an antigen to initiating digestion, stimulating the secretion of digestive acids and enzymes, increasing the blood flow and stimulating |
| 02/22/2000 | US6027734 To provide protection against pneumococcal colonization and systemic infection, intranasally administering a composition consisting essentially of pneumococcal surface protein a or a fragment containing a protection-eliciting epitope |
| 02/22/2000 | US6027733 Method for generating saccharide fragments |
| 02/22/2000 | US6027732 Iscom or iscom-matrix comprising hydrophobic receptor molecules for antigenic substances |
| 02/22/2000 | US6027730 Herpes simplex vaccine comprising HSV glycoprotein GD and 3 deacylated monophosphoryl lipid A |
| 02/22/2000 | US6027729 An isolated polypeptide comprising an amino acid sequence of at least 12 contiguous amino acids encoded by a non-a, non-b hepatitis virus, i.e., hepititis c, genome; managing infection spread; medical diagnosis; evaluation of library |
| 02/22/2000 | US6027727 Inducing transient infertility in a mammal by administering a dose of recombinant zona pellicida proteins from a cat, cattle or cynomolgous monkey and human to stimulate antibody production; vaccines |
| 02/22/2000 | CA2063303C Preparation of virus-free immunoglobulins |
| 02/22/2000 | CA2003455C Immunotherapy involving cd28 stimulation |
| 02/22/2000 | CA1340910C Fibronectin binding protein |
| 02/22/2000 | CA1340907C Synthetic antigen evoking anti-hiv responese |